PATENT CLAIM ANALYSIS

Application Number: 15936686
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-08
Patent Classification: ["424", "134100"]

Abstract:
The present disclosure relates to a method for the treatment of a non-pathogen associated inflammatory disorders in a subject in need thereof, comprising administering to said subject an isolated peptide which specifically binds to an amino acid sequence within the dimer interface of a T cell costimulatory pathway member, particularly the T cell costimulatory pathway members CD28 and CTLA4. The present disclosure also relates to pharmaceutical compositions comprising the isolated peptide and to use of the peptide in treating of a non-pathogen associated inflammatory disorders.

Claim (Index 10):
The isolated peptide or pharmaceutical composition for use according to any one of  claims 1  and  2 , wherein said isolated peptide is a peptide consisting of the amino acid sequence Ser His Phe Thr His Asn Arg His Gly His Ser Thr (denoted by SEQ ID NO: 12). (D-Ala) Ser His Phe Thr His Asn Arg His Gly His Ser Thr (D-Ala) (denoted by SEQ ID NO: 49) and (palmitoyl-lysine) Ser His Phe Thr His Asn Arg His Gly His Ser Thr D-Ala) (denoted by SEQ ID NO: 51).

Metadata:
- Claim Count in Document: 17.0
- Percentile: 90.0
- Lexical Diversity: 1.7451
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15035571', '15558080', '13392548', '09888324', '14398260']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8169011938372293
- 35 USC 102 Novelty (BERT): 0.6936859254572962
- Combined Prediction Score: 0.8045796669992359
- Mean Citation Score: 509.97055599999993
- Max Citation Score: 840.2424300000001
- Similarity Product: 692.5040503761777

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test